News & Articles

Simplified design reduces manufacturing time and offers improved functionality to help streamline antibody discovery, cell line development, cell therapy, and synthetic biology workflows

Platform poised to be first CLIA-waived CRISPR-based, point-of-care COVID-19 device with central-lab performance, developed in collaboration with Sherlock Biosciences

Explore topics from live-cell analysis, in situ hybridization, cancer therapeutics, cell imaging, and much more

Genome editing experts harness the power of CRISPR-Cas enzymes to power the next diagnostic revolution in COVID-19 detection and diagnosis

Explore topics from perfume profiling, salmonella spp. detection, regulatory biopharma compliance, and in situ hybridization

From DNA extraction kits to pipettes and imaging systems, find out the latest products to join the exclusive ranks of lab equipment most loved by scientists across the world

License agreement to enhance GenScript’s CRISPR offering for gene and cell therapy research

FDA Breakthrough Device Designation for Sepsis, Joint & Implant Infections, Infective Endocarditis, Bacterial Meningitis

Scientific, technological and communications excellence has been celebrated at the Virtual Cancer and Immunology Research Summit, with Logos Biosystems, INTEGRA Biosciences and Sartorius among those recognized

Discover how collaborative research between big pharma and academia is using the latest proteomics platforms to revolutionize drug discovery

Explore topics from HRIM-MS for enhancing structural characterization to microbial monitoring, in situ hybridization and advances in fragrance profiling

Discover how to increase precision and reduce throughput time of your routine electrolyte analyses

Company rapidly expanding commercial operations to enable more researchers to extract higher yields of DNA and RNA from FFPE samples in one hour with minimal hands-on time

Catch up on this expert webinar to discover the customizable screening service helping to drive the validation of novel cancer therapies

Infectious disease expert shares how robust LC columns are facilitating the analysis of complex pathogen samples

Explore topics from LC-MS for oligos, peptides, glycans, and large molecule characterization to 3D cell culture for anticancer therapies

Dr. Raul Cano, Chief Scientific Officer at The BioCollective, discusses how to increase sequencing data accuracy and reproducibility and the future of the microbiome in healthcare